<DOC>
	<DOCNO>NCT00139178</DOCNO>
	<brief_summary>Highly active antiretroviral therapy ( HAART ) improve long time survival HIV infected individual . However increase number HIV-patients develop metabolic morphological alteration include peripheral lipoatrophy . The main hypothesis study switch thymidine-analogue base HAART reverse lipoatrophy . We plan perform observational study recruit 100 HIV-infected patient receive Trizivir ( zidovudine/lamivudine/abacavir ) . The patient offer NRTI lopinavir/ritonavir instead zidovudine choose continue Trizivir . The main endpoint change peripheral fat mass determine DEXA-scanning .</brief_summary>
	<brief_title>Switching From Zidovudine NNRTI Lopinavir/Ritonavir Patients Treated With Zidovudine/ Lamivudine/Abacavir .</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Lipodystrophy</mesh_term>
	<mesh_term>HIV-Associated Lipodystrophy Syndrome</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Currently treat lamivudine , zidovudine abacavir Viral load &lt; 200 copies/ml Ability understand provide write informed consent . Women pregnant breastfeeding . Fertile woman use safe contraception . Patients active intravenous drug use . Abuse alcohol , opinion treat physician reduce patientÂ´s ability follow therapeutic regimen evaluation protocol . Creatinine &gt; 200 mmol/l . ALT AST &gt; 5 time upper normal value ( 200U/l ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
</DOC>